Eli Lilly Halves €2.3B Investment in Germany
Eli Lilly (LLY) has decided to reduce its planned investment in Germany by half due to a strategic shift focusing on the U.S. market, according to CEO Dave Ricks.
Tickers: $LLY
More World news
- Nvidia Shares Plunge Following Resignation of CEO Jensen Huang
- Jensen Huang Resigns as Nvidia CEO; Colette Kress Appointed Interim CEO
- Merck KGaA Raises 2026 Outlook Amid Pending Bio-Techne Acquisition
- Chinese AI Firms Seek Alternative Access to Nvidia Chips Amid Potential US Export Restrictions
- Purcell & Lefkowitz LLP Launches Shareholder Investigation into Dick's Sporting Goods
- Pomerantz Law Firm Investigates Fervo Energy Following Allegations of Securities Fraud
- Pomerantz Law Firm Investigates Boston Scientific Following Q3 Earnings Miss and Guidance Downgrade
- Jensen Huang Concludes 33-Year Tenure as CEO of Nvidia
- Metalla Royalty & Streaming Reports Q3 Revenue Growth and Increased Adjusted EBITDA
- Fed Governor Michael Barr Warns AI Market Concentration Could Drive Income Inequality